ARCHIVES

FDA Proposal On Dissemination of Off-Label Drug Information Doesn’t Go Far Enough, Cancer Groups Say

This article is from The Cancer Letter archive.

Vol. 22 No. 04 | January 26, 1996

Download PDF Visit The Full Archive

Related Articles

NCI’s Weinstein Said He Never Pressured Researcher

November 3, 1995

ASCO, AACR Call NCI Bypass Budget A Key Advocacy Tool, Seek Larger Role In Writing It.

July 14, 2000

Move to Boycott Cancer Congress Gains Some Support

January 20, 1978

Funding opportunities listed.

October 15, 2004

Report calls for stronger peer review, prioritization for cancer clinical trials.

June 10, 2005

CTEP Deploys Website To Track Trial Activation

December 10, 2010